Boehringer Ingelheim is a global pharmaceutical leader with over 53,000 employees dedicated to advancing health through innovation. Specializing in human and animal healthcare, the company offers a range of products including biopharmaceuticals, contract manufacturing, and research services. Committed to improving lives worldwide, Boehringer Ingelheim's collaborative culture drives breakthroughs in pharmaceutical science.
We are seeking a Senior Principal Scientist to drive in silico evidence generation and advance novel therapeutic candidates through various milestones. This role will leverage advanced computational approaches to elucidate mechanisms of action and facilitate late-stage project transitions.
Boehringer Ingelheim is a global pharmaceutical leader with over 53,000 employees dedicated to advancing health through innovation. Specializing in human and animal healthcare, the company offers a range of products including biopharmaceuticals, contract manufacturing, and research services. Committed to improving lives worldwide, Boehringer Ingelheim's collaborative culture drives breakthroughs in pharmaceutical science.
Kernal Biologics